Jindan Sheng
Shanghai, 200092, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway.
Journal: Biomedicines
Published: January 11, 2026
Deprivation of EGFR signal causes senolysis in PDAC with CDK4/6 inhibition.
Journal: Cell death and differentiation
Published: April 02, 2025
Targeting CDK9 With Harmine Induces Homologous Recombination Deficiency and Synergizes With PARP Inhibitors in Ovarian Cancer.
Journal: Phytotherapy research : PTR
Published: November 16, 2024
CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: November 23, 2023
Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.
Journal: Biomolecules
Published: September 12, 2023
Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer.
Journal: Cancer cell international
Published: June 12, 2023
Treatment of Retinoblastoma 1-Intact Hepatocellular Carcinoma With Cyclin-Dependent Kinase 4/6 Inhibitor Combination Therapy.
Journal: Hepatology (Baltimore, Md.)
Published: November 03, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026